SCHEMBL5378586

SCHEMBL5378586

COc1ccc(-c2nc3ccc(C(C)(C)c4ccccc4)cc3c(=O)o2)cc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.66
MAPT P10636 7/20 0.66
KDM4E B2RXH2 5/20 0.66
NPC1 O15118 5/20 0.66
SMN1; SMN2 Q16637 4/20 0.66
RAB9A P51151 4/20 0.66
LMNA P02545 2/20 0.66
HPGD P15428 4/20 0.55
F2 P00734 1/20 0.53
KMT2A Q03164 1/20 0.53
C1R P00736 1/20 0.53
HSD17B10 Q99714 1/20 0.52
TP53 P04637 6/20 0.50
XBP1 P17861 1/20 0.47
ELANE P08246 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
RXFP1 Q9HBX9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14462683 0.92 NPC1 (0.55) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL5382664 0.89 ELANE (0.57) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL5382380 0.89 ALDH1A1 (0.69) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL5380224 0.86 NPC1 (0.49) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL5381518 0.85 MAPT (0.54) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL5376982 0.83 RAB9A (0.46) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL5387023 0.82 C1R (0.66) ALDH1A1KDM4ENPC1HPGDKMT2A
SCHEMBL5376370 0.82 NPC1 (0.73) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL2537004 0.81 MAPT (0.72) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL14462682 0.81 F7 (0.45) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7244776-B2 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-07-17 US disclosed
US-20070100031-A1 Ultraviolet light absorbers RAVICHANDRAN RAMANATHAN 2007-05-03 US disclosed
US-7173128-B2 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-02-06 US disclosed
US-20040192684-A1 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION 2004-09-30 US disclosed
EP-1430038-A1 ULTRAVIOLET LIGHT ABSORBERS Ciba SC Holding AG (CH) 2004-06-23 EP disclosed
WO-2003016292-A1 ULTRAVIOLET LIGHT ABSORBERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192684-A1 Ultraviolet light absorbers UNG, MSH6, MAL2 ALDH1A1 131/4885MAPT 904/4885KDM4E 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.